[Bisphosphonate therapy in corticoid-induced osteoporosis].
Ringe
J D
JD
Medizinische Klinik 4, Klinikum Leverkusen.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D002118:Calcium / Q000008:administration & dosage; D004164:Diphosphonates / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000008:administration & dosage; D012968:Etidronic Acid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy*; D000077268:Pamidronate; D017698:Postmenopause; D011372:Progestins / Q000008:administration & dosage; D013997:Time Factors; D014807:Vitamin D / Q000008:administration & dosage
D000305:Adrenal Cortex Hormones; D004164:Diphosphonates; D004967:Estrogens; D006887:Hydroxycholecalciferols; D011372:Progestins; D014807:Vitamin D; D012968:Etidronic Acid; D000077268:Pamidronate; D002118:Calcium; C008088:alfacalcidol